Gossamer Bio, Inc.GOSSNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P20
Within normal range
vs 5Y Ago
-1.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-33.59%
Q3 202523.15%
Q2 2025-18.47%
Q1 2025-11.96%
Q4 2024-10.76%
Q3 2024-127.53%
Q2 2024322.45%
Q1 2024-56.48%
Q4 20233.10%
Q3 20239.82%
Q2 202327.81%
Q1 2023-11.02%
Q4 2022-29.01%
Q3 202224.22%
Q2 20228.71%
Q1 2022-32.03%
Q4 20213.63%
Q3 202111.41%
Q2 202119.43%
Q1 2021-60.32%
Q4 202018.24%
Q3 2020-5.97%
Q2 202018.92%
Q1 2020-18.48%
Q4 2019-22.24%
Q3 20191.90%
Q2 2019-32.53%
Q1 2019-10.99%
Q4 2018-61.28%
Q3 2018-128.23%
Q2 2018-83.33%
Q1 201835.19%
Q4 2017-23737.50%
Q3 20170.00%
Q2 20170.00%
Q1 20170.00%